2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESCShow others and affiliations
2022 (English)In: European Journal of Heart Failure, ISSN 1388-9842, E-ISSN 1879-0844, Vol. 24, no 1Article in journal (Refereed) Published
Abstract [en]
n/a
Place, publisher, year, edition, pages
WILEY , 2022. Vol. 24, no 1
Keywords [en]
Guidelines; heart failure; natriuretic peptides; ejection fraction; diagnosis; pharmacotherapy; neuro-hormonal antagonists; cardiac resynchronization therapy; mechanical circulatory support; transplantation; arrhythmias; comorbidities; hospitalization; multidisciplinary management; advanced heart failure; acute heart failure
National Category
Nursing
Identifiers
URN: urn:nbn:se:liu:diva-183793DOI: 10.1002/ejhf.2333ISI: 000754415600002PubMedID: 35083827OAI: oai:DiVA.org:liu-183793DiVA, id: diva2:1649197
Note
All experts involved in the development of these guidelines have submitted declarations of interest. These have been compiled in a report and published in a supplementary document simultaneously to the guidelines. The report is also available on the ESC website www.escardio.org/guidelines (C) For the Supplementary Data which include background information and detailed discussion of the data that have provided the basis for the guidelines see European Heart Journal online
2022-04-042022-04-042022-04-04